pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-433 |
Genomic Coordinates | chr14: 100881886 - 100881978 |
Synonyms | MIRN433, hsa-mir-433, miRNA433, MIR433 |
Description | Homo sapiens miR-433 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-433-3p | ||||||||||||
Sequence | 64| AUCAUGAUGGGCUCCUCGGUGU |85 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FGF20 | ||||||||||||||||||||
Synonyms | FGF-20, RHDA2 | ||||||||||||||||||||
Description | fibroblast growth factor 20 | ||||||||||||||||||||
Transcript | NM_019851 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FGF20 | |||||||||||||||||||||
3'UTR of FGF20 (miRNA target sites are highlighted) |
>FGF20|NM_019851|3'UTR
1 AGTGCGATAGTGACATTATGGAAGAGTCAAACCACAACCATTCTTTCTTGTCATAGTTCCCATCATAAAATAATGACCCA
81 AGGAGACGTTCAAAATATTAAAGTCTATTTTCTACTGAGAGACTGGATTTGGAAAGAATATTGAGAAAAAAAACCAAAAA
161 AAATTTTGACTAGAAATAGATCATGATCACTCTTTATATGTGGATTAAGTTCCCTTAGATACATTGGATTAGTCCTTACC
241 AGTAGAC
Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Neuro2A |
Location of target site | 3'UTR |
Original Description (Extracted from the article) |
...
"We hypothesized that miR-433 would bind tightly to FGF20 mRNA transcripts containing the C allele
... - Wang G; van der Walt JM; Mayhew G; Li YJ; et al., 2008, American journal of human genetics. |
Article |
- Wang G; van der Walt JM; Mayhew G; Li YJ; et al. - American journal of human genetics, 2008
Parkinson disease (PD) is a common neurodegenerative disorder caused by environmental and genetic factors. We have previously shown linkage of PD to chromosome 8p. Subsequently, fibroblast growth factor 20 (FGF20) at 8p21.3-22 was identified as a risk factor in several association studies. To identify the risk-conferring polymorphism in FGF20, we performed genetic and functional analysis of single-nucleotide polymorphisms within the gene. In a sample of 729 nuclear families with 1089 affected and 1165 unaffected individuals, the strongest evidence of association came from rs12720208 in the 3' untranslated region of FGF20. We show in several functional assays that the risk allele for rs12720208 disrupts a binding site for microRNA-433, increasing translation of FGF20 in vitro and in vivo. In a cell-based system and in PD brains, this increase in translation of FGF20 is correlated with increased alpha-synuclein expression, which has previously been shown to cause PD through both overexpression and point mutations. We suggest a novel mechanism of action for PD risk in which the modulation of the susceptibility gene's translation by common variations interfere with the regulation mechanisms of microRNA. We propose this is likely to be a common mechanism of genetic modulation of individual susceptibility to complex disease.
LinkOut: [PMID: 18252210]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
75 hsa-miR-433-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT001201 | GRB2 | growth factor receptor bound protein 2 | 3 | 1 | ||||||||
MIRT001741 | FGF20 | fibroblast growth factor 20 | 3 | 1 | ||||||||
MIRT007225 | RUNX2 | runt related transcription factor 2 | 1 | 1 | ||||||||
MIRT007361 | CFTR | cystic fibrosis transmembrane conductance regulator | 1 | 1 | ||||||||
MIRT016630 | HDAC6 | histone deacetylase 6 | 1 | 1 | ||||||||
MIRT053561 | KRAS | KRAS proto-oncogene, GTPase | 3 | 1 | ||||||||
MIRT082022 | COX6B1 | cytochrome c oxidase subunit 6B1 | 2 | 4 | ||||||||
MIRT086929 | CREB1 | cAMP responsive element binding protein 1 | 3 | 1 | ||||||||
MIRT096407 | C5ORF22 | chromosome 5 open reading frame 22 | 2 | 2 | ||||||||
MIRT135569 | SPRYD4 | SPRY domain containing 4 | 2 | 2 | ||||||||
MIRT143520 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT167706 | HIVEP1 | human immunodeficiency virus type I enhancer binding protein 1 | 2 | 8 | ||||||||
MIRT207568 | STARD7 | StAR related lipid transfer domain containing 7 | 2 | 4 | ||||||||
MIRT252052 | WDR45B | WD repeat domain 45B | 2 | 2 | ||||||||
MIRT327787 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT406144 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT437355 | GBP2 | guanylate binding protein 2 | 3 | 1 | ||||||||
MIRT438242 | TYMS | thymidylate synthetase | 3 | 1 | ||||||||
MIRT438553 | AZIN1 | antizyme inhibitor 1 | 4 | 1 | ||||||||
MIRT444186 | SCAMP1 | secretory carrier membrane protein 1 | 2 | 2 | ||||||||
MIRT477737 | EDN1 | endothelin 1 | 2 | 2 | ||||||||
MIRT483052 | SMU1 | DNA replication regulator and spliceosomal factor | 2 | 2 | ||||||||
MIRT485778 | ATXN1 | ataxin 1 | 2 | 2 | ||||||||
MIRT498142 | FKBP1C | FK506 binding protein 1C | 2 | 4 | ||||||||
MIRT499050 | SSC5D | scavenger receptor cysteine rich family member with 5 domains | 2 | 8 | ||||||||
MIRT501959 | MAPK8 | mitogen-activated protein kinase 8 | 2 | 2 | ||||||||
MIRT503281 | TMEM229B | transmembrane protein 229B | 2 | 4 | ||||||||
MIRT503597 | ZNF780A | zinc finger protein 780A | 2 | 2 | ||||||||
MIRT504577 | UGT2B4 | UDP glucuronosyltransferase family 2 member B4 | 2 | 4 | ||||||||
MIRT506727 | LONRF2 | LON peptidase N-terminal domain and ring finger 2 | 2 | 2 | ||||||||
MIRT523130 | HSP90B1 | heat shock protein 90 beta family member 1 | 2 | 4 | ||||||||
MIRT531338 | TGIF2LX | TGFB induced factor homeobox 2 like, X-linked | 2 | 2 | ||||||||
MIRT534928 | PTPLAD1 | 3-hydroxyacyl-CoA dehydratase 3 | 1 | 1 | ||||||||
MIRT536233 | LRIG3 | leucine rich repeats and immunoglobulin like domains 3 | 2 | 2 | ||||||||
MIRT537092 | GPR135 | G protein-coupled receptor 135 | 2 | 2 | ||||||||
MIRT548286 | FAM3C | family with sequence similarity 3 member C | 2 | 4 | ||||||||
MIRT549143 | BRWD1 | bromodomain and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT556354 | MAFK | MAF bZIP transcription factor K | 2 | 2 | ||||||||
MIRT557839 | FKBP1A | FK506 binding protein 1A | 2 | 2 | ||||||||
MIRT564080 | NSA2 | NSA2, ribosome biogenesis homolog | 2 | 2 | ||||||||
MIRT566382 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT573110 | ERBB2IP | erbb2 interacting protein | 2 | 2 | ||||||||
MIRT574403 | TFAP2A | transcription factor AP-2 alpha | 2 | 2 | ||||||||
MIRT576063 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT619449 | TCF20 | transcription factor 20 | 2 | 2 | ||||||||
MIRT632928 | FGF9 | fibroblast growth factor 9 | 2 | 2 | ||||||||
MIRT633216 | ZNF584 | zinc finger protein 584 | 2 | 2 | ||||||||
MIRT633654 | SLC28A1 | solute carrier family 28 member 1 | 2 | 2 | ||||||||
MIRT637198 | KLHL4 | kelch like family member 4 | 2 | 2 | ||||||||
MIRT646480 | SPATS2L | spermatogenesis associated serine rich 2 like | 2 | 2 | ||||||||
MIRT648314 | SCNN1G | sodium channel epithelial 1 gamma subunit | 2 | 2 | ||||||||
MIRT648631 | LEMD2 | LEM domain containing 2 | 2 | 2 | ||||||||
MIRT655902 | NEK9 | NIMA related kinase 9 | 2 | 2 | ||||||||
MIRT667805 | ITIH5 | inter-alpha-trypsin inhibitor heavy chain family member 5 | 2 | 2 | ||||||||
MIRT675464 | NUBPL | nucleotide binding protein like | 2 | 2 | ||||||||
MIRT675974 | FAM126B | family with sequence similarity 126 member B | 2 | 2 | ||||||||
MIRT676145 | ALDOA | aldolase, fructose-bisphosphate A | 2 | 2 | ||||||||
MIRT676895 | GABPB1 | GA binding protein transcription factor beta subunit 1 | 2 | 2 | ||||||||
MIRT677459 | PDLIM3 | PDZ and LIM domain 3 | 2 | 2 | ||||||||
MIRT677533 | TM4SF5 | transmembrane 4 L six family member 5 | 2 | 2 | ||||||||
MIRT677641 | HAUS2 | HAUS augmin like complex subunit 2 | 2 | 2 | ||||||||
MIRT678806 | HRH4 | histamine receptor H4 | 2 | 2 | ||||||||
MIRT679693 | SLC1A5 | solute carrier family 1 member 5 | 2 | 4 | ||||||||
MIRT679707 | RPL24 | ribosomal protein L24 | 2 | 2 | ||||||||
MIRT698822 | STK38 | serine/threonine kinase 38 | 2 | 2 | ||||||||
MIRT701796 | MRPS25 | mitochondrial ribosomal protein S25 | 2 | 2 | ||||||||
MIRT702220 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT706095 | ENTPD4 | ectonucleoside triphosphate diphosphohydrolase 4 | 2 | 2 | ||||||||
MIRT706502 | MTMR9 | myotubularin related protein 9 | 2 | 2 | ||||||||
MIRT709780 | NINJ1 | ninjurin 1 | 2 | 2 | ||||||||
MIRT713859 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 2 | ||||||||
MIRT715807 | BBS2 | Bardet-Biedl syndrome 2 | 2 | 2 | ||||||||
MIRT724229 | DGKE | diacylglycerol kinase epsilon | 2 | 2 | ||||||||
MIRT731338 | MET | MET proto-oncogene, receptor tyrosine kinase | 1 | 1 | ||||||||
MIRT731849 | HIF1A | hypoxia inducible factor 1 alpha subunit | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|